Hot Healthcare Technology Stocks To Invest In 2014

Costco� (NASDAQ: COST  ) beat earnings with positive numbers all around, except for its stock price on the day. Even with earnings rising 19% from a year ago, revenue up 8%, and revenue from stores open at least one year up 5%, the stock fell nearly 1%. Of course, a daily stock move shouldn't worry long-term investors. And sometimes more important than the raw numbers is what's hidden in the earnings call.

Here's what you need to know from Costco's recent earnings call.

Increasing openings
CFO Richard Galanti discusses the increasing expansion: "Between now and September 1, the end of our fiscal year, we expect to open an additional nine locations, three in the U.S., three in Japan, and one each in the U.K., Taiwan, and Australia, such that we'll most likely end the fiscal year with 28 new openings for the year. That's up from 16 net openings in fiscal 2012."

Of Costco's 627 stores, 449 are in the United States. This presents a huge opportunity in countries where it is just getting started, like Australia, where it only has three stores. And for Costco, where stores perform better as they get older due to building up the local membership roll, the sooner it builds them, the better off its future will be.

Hot Valued Companies To Buy Right Now: Guided Therapeutics Inc (GTHP)

Guided Therapeutics, Inc., incorporated on October 27, 1992, is a medical technology company focused on developing medical devices. The Company�� primary focus is the development of its LuViva non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, especially esophageal. Its technology, including products in research and development, primarily relate to biophotonics technology for the non-invasive detection of cancers. LuViva is a non-invasive cervical cancer detection product, based on the Company's biophotonic technology. The device is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix.

The Company's product, in addition to detecting the structural changes attributed to cervical cancer, is also designed to detect the biochemical changes that precede the development of visual lesions. The product is expected to incorporate a single-use, disposable calibration and alignment component.

The Company competes with Qiagen, MediSpectra, Inc., Merck & Co., Inc., and GlaxoSmithKline PLC.

Advisors' Opinion:

• [By CRWE]

  Last Friday, GTHP had shed (-2.16%) down -0.015 at $.679 with 39,538 shares in play at the close (ref. google finance August 23, 2013 ��Close).

  Guided Therapeutics, Inc. previously reported its operating results for the second quarter and six months ended June 30, 2013.

  Revenue and other income for the second quarter of 2013 was approximately $338,000, including $116,000 in sales of LuViva庐 devices and disposables associated with its European launch, with the remainder of revenue representing contract and grant income. This compares to revenue of approximately $944,000 in the second quarter of 2012, which was comprised almost solely of contract and grant income. Revenue for the first six months of 2013 was $637,000, including $248,000 in sales of LuViva device and disposables. Revenue in the first six months of 2012 was $1.6 million, which was comprised almost solely of contract and grant income. The year over year decline in contract and grant income for both periods was primarily due to bringing the worldwide rights to the Company�� esophageal cancer detection technology back in house.

• [By CRWE]

  Today, GTHP remains (0.00%) +0.000 at $.710 with 44,700 shares in play thus far (ref. google finance Delayed: 11:42AM EDT August 21, 2013).

  Guided Therapeutics, Inc. previously reported its operating results for the second quarter and six months ended June 30, 2013.

  Revenue and other income for the second quarter of 2013 was approximately $338,000, including $116,000 in sales of LuViva庐 devices and disposables associated with its European launch, with the remainder of revenue representing contract and grant income. This compares to revenue of approximately $944,000 in the second quarter of 2012, which was comprised almost solely of contract and grant income. Revenue for the first six months of 2013 was $637,000, including $248,000 in sales of LuViva device and disposables. Revenue in the first six months of 2012 was $1.6 million, which was comprised almost solely of contract and grant income. The year over year decline in contract and grant income for both periods was primarily due to bringing the worldwide rights to the Company�� esophageal cancer detection technology back in house.

Hot Healthcare Technology Stocks To Invest In 2014: Asanko Gold Inc (AKG)

Asanko Gold Inc., incorporated on September 23, 1999, is a natural resource company engaged in the acquisition and exploration of mineral resources in West Ghana. Its mineral properties are in the exploration and development stage. Its primary property is the Esaase project. The Company is focused on advancing the Esaase Gold Project to commercial production. In addition to its principal project, the Company holds a portfolio of other Ghanaian gold concessions in various stages of exploration. As of February 28, 2014, the Company�� material properties consisted of the Asanko Gold Mine project, the Asumura Property and the Diaso Property, all in West Ghana, Africa. In February 2014, Asanko Gold Inc successfully completed the acquisition of PMI Gold Corporation.

Asanko Gold Mine Property

The Asanko Gold Mine Property is a development stage property located in the Amansi East District of Ghana, approximately 35 kilometers south west of the regional capital Kumasi. The property comprises the Nkran pit, the Adubiaso pit, the Dynamite Hill deposit, the Asuadai deposit, the Abore pit and the Esaase deposit. The Property has gold resources of approximately 7.52 million ounces and gold reserves of approximately 4.81 million ounces.

The Asumura Property

The Asumura Property is without known resources or reserves and the work being done by the Company is exploratory in nature. The Asumura Property is located in the south-western part of Ghana and is divided into two parts by the Bia River. The western part of the property is within the Western Region of Ghana in the Juabeso Bia District and the eastern part is in the Brong Ahafo Region of Ghana. The Asumura Property consists of two exploration concessions: Fosukrom and Asumura, which together equal 279.4 square kilometers.

Advisors' Opinion:

• [By MONEYMORNING]

  As well, Primero Mining (NYSE: PPP) bought Brigus Gold Corp (USA)(NYSE: BRD) for $220 million, and Asanko Gold (NYSEMKT: AKG) is acquiring PMI Gold Corporation (TSE: PMV).

Hot Healthcare Technology Stocks To Invest In 2014: BPZ Resources Inc (BPZ)

BPZ Resources, Inc., together with its subsidiaries, focuses on the exploration, development, and production of oil and natural gas in Peru and Ecuador. It owns rights and license agreements for oil and gas exploration and production covering approximately 2.2 million acres in 4 blocks in northwest Peru and off the northwest coast of Peru in the Gulf of Guayaquil. The company also owns a 10% non-operating net profits interest in an oil and gas producing property located in the southwest region of Ecuador. As of December 31, 2011, it had estimated net proved oil reserves of 34.7 million barrels (MMBbls) of crude oil or other liquid hydrocarbons, including 27.8 MMBbls were in the Corvina field and 6.9 MMBbls were from the Albacora field located in northwest Peru. The company was founded in 2001 and is headquartered in Houston, Texas.

Advisors' Opinion:

• [By Lee Jackson]

  BPZ�Resources Inc. (NYSE: BPZ) may be a small cap investor’s dream stock to buy. Its first well drilled�in the Corvina�field since 2010 was spudded in late July and likely will take about 12 weeks. It will take another week or so to achieve a stabilized flow rate before results are reported to the market, which means it will not expect to hear anything until November. The Raymond James price target for the stock is $4.50, the same as the consensus target.

Hot Healthcare Technology Stocks To Invest In 2014: StoneMor Partners L.P.(STON)

StoneMor Partners L.P., together with its subsidiaries, engages in the ownership and operation of cemeteries in the southeast, northeast, and west regions of the United States. It offers funeral and cemetery products and services in the death care industry. The company sells interment rights, caskets, burial vaults, cremation niches, markers, and other cemetery related merchandise; provides opening and closing that is the digging and refilling of burial spaces to install the vault and place the casket into the vault; and various other services, including the installation of other cemetery merchandise and the perpetual care related to interment rights. It also offers various funeral-related services, such as family consultation, the removal of and preparation of remains, and the use of funeral home facilities for visitation. As of December 31, 2011, it operated 274 cemeteries, including 253 own cemeteries in 26 states and Puerto Rico; and owned and operated 69 funeral homes in 18 states and Puerto Rico. StoneMor GP LLC serves as the general partner of the company. StoneMor Partners L.P. was founded in 1999 and is headquartered in Levittown, Pennsylvania.

Advisors' Opinion:

• [By Dr. Kent Moors]

  Of course, there are some exceptions. My favorite outlier, about as non-oil and gas as you can get, is StoneMor Partners LP (NYSE: STON). StonMor is an MLP that manages cemeteries... and it pays a 9.5% yield!

Hot Healthcare Technology Stocks To Invest In 2014: Gale Pacific Ltd (GAP)

Gale Pacific Limited is an Australia-based company engaged in marketing, sales, manufacture and distribution of screening, shading and home improvement products to global markets.The Company operates in one business segment, being the branded shading, screening and home improvement products. The Company products are sold to consumer and industrial markets including the retail and home furnishing, architectural, construction, and agribusiness markets. The Company manufactures sources and markets advanced durable knitted and woven polymer fabrics and structures made from these fabrics. The Company's retail products are marketed under the Coolaroo brand. The Company's retail product lines include items such as shade fabrics, exterior window furnishings, gazebos, shade sails and a range of pet products. The Company sells its products in Australia, the Unites States, Europe, the Middle East, New Zealand and a number of other export markets. Advisors' Opinion:

• [By Dimitra DeFotis]

  Some trends and percentages:

  Department store Thanksgiving online sales grew by 60% vs 2012, with mobile sales growing by 44% year over year. Perhaps a boost for clothing purveyors like Gap (GAP), whose shares are up 1% in morning trading : total online sales of apparel on Thanksgiving grew by about 41% vs. 2012, with mobile sales growing by close to 62.4% year over year. Shares of�Macy’s�(M) are flat this morning, while shares of women’s clothing seller Chico�� Fas�(CHS) are down 0.4%. Mobile represented nearly 26